Watchlist Price Alert

Orchestra BioMed Inc. (OBIO)

NASDAQ: OBIO · Real-Time Price · USD

2.81

-0.17 (-5.70%)

At close: Jun 27, 2025, 3:59 PM

2.78

-0.93%

After-hours: Jun 27, 2025, 05:58 PM EDT

Orchestra BioMed Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-61.02M	-49.12M	-33.61M	-23.01M	-21.36M
Depreciation & Amortization	308K	287K	222K	181K	137K
Stock-Based Compensation	10.62M	7.63M	3.41M	302K	221K
Other Working Capital	-3.73M	-3.58M	-451K	1.47M	-5.41M
Other Non-Cash Items	308K	-1.61M	4.77M	217K	2.93M
Deferred Income Tax	n/a	n/a	-3.63M	288K	n/a
Change in Working Capital	-765K	-3.31M	-451K	2.6M	-8.12M
Operating Cash Flow	-50.56M	-46.13M	-29.29M	-19.43M	-26.18M
Capital Expenditures	-289K	-78K	-591K	-274K	-539K
Cash Acquisitions	-602K	n/a	-29.06M	-13.29M	-27.5M
Purchase of Investments	-72.65M	-142.03M	-63.53M	-213K	-15.62M
Sales Maturities Of Investments	86.63M	152.8M	92.59M	13.5M	43.13M
Other Investing Acitivies	n/a	n/a	-63.53M	13.29M	27.5M
Investing Cash Flow	13.09M	10.69M	-64.12M	13.02M	26.97M
Debt Repayment	15M	-10.85M	3.55M	-4M	10M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.1M	57.06M	-10.13M	7K	n/a
Financial Cash Flow	29.17M	46.22M	103.26M	-3.99M	10M
Net Cash Flow	-8.3M	10.78M	18.03M	-10.4M	10.78M
Free Cash Flow	-50.85M	-46.2M	-29.88M	-19.7M	-26.72M